IPO Date: Dec 20 to Dec 24 2024
Listing Date: Dec 30 2024
1.Investment in one of our Subsidiaries, Havix Group, Inc. d/b/a Aavis Pharmaceuticals (“Havix”), to fund capital expenditure requirements for setting up a manufacturing facility for the production of sterile injections in our Atlanta Facility.
2.Re-payment/pre-payment, in full or in part, of certain borrowings availed by our Company.
3.Investment in our Subsidiary, namely, Havix, for re- payment/pre-payment in full or in part, of certain borrowings availed by such Subsidiary.
4.Funding the working capital requirements of our Company.
5.Investment in our Subsidiaries, namely, Senores Pharmaceuticals Inc. (“SPI”) and Ratnatris Pharmaceutical Private Limited (“Ratnatris”) to fund their working capital requirements.
6.Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes.
1101 To 1103, 11th Floor, South Tower One 42 Opp. Jayantilal Park Ambali Bopal Road
Ahmedabad
Gujarat
380054
079-29999857
info@senorespharma.com
www.senorespharma.com
MUFG Intime India Pvt Ltd.
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pace Digitek has informed that it enclosed a Press Release dated July 21, 2026, regarding Lineage Power (‘LPPL’), a material subsidiary which has established a dedicated Research & Development (R&D) Centre in Pune to strengthen its research, engineering, and technology capabilities in advanced battery technologies including Advanced Chemistry Cells (ACC) and energy storage solutions. As part of this initiative, Lineage Power has entered into a research collaboration with the Indian Institute of Science Education and Research (IISER), Pune, to undertake research on advanced battery technologies and battery materials.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Senores Pharmaceuticals Ltd. IPO is ₹317.49 - 333.71 crore.
The Senores Pharmaceuticals Ltd. IPO opens for subscription on 2024-12-20 and closes on 2024-12-24.
The price range of Senores Pharmaceuticals Ltd. IPO is ₹372.00 to ₹391.00.
The lot size of Senores Pharmaceuticals Ltd. IPO is 38 shares.
The registrar of Senores Pharmaceuticals Ltd. IPO is MUFG Intime India Pvt Ltd..
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.